Evidence map›Paper›PMID 32328932›Full record

ArticleEuropean journal of drug metabolism and pharmacokinetics2020

Elution Profiles of Synthetic CaSO

Gerhard E Maale, John J Eager, Daniel K Mohammadi, Flavio A Calderon

Open access · hybridAbstract read
In one paragraph

Article in European journal of drug metabolism and pharmacokinetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The stability of Staphylococcal bacteriophage in presence of local vancomycin concentrations used in clinical practice.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024
    Article
  7. Article
  8. New bone formation using antibiotic-loaded calcium sulfate beads in bone transports for the treatment of long-bone osteomyelitis.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Prevention and Killing Efficacy of Carbapenem ResistantMaterials (Basel, Switzerland) · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gerhard E MaaleOrthopaedic Oncology, Dallas Fort Worth Sarcoma Group, 4708 Alliance Blvd Ste 710., Plano, TX, 75093, USA. gmaale@dfwsarcoma.com.
John J EagerUniversity of Texas Medical School At Houston, 6431 Fannin Street, Box 20708, Houston, TX, 77225, USA.
Daniel K MohammadiOrthopaedic Oncology, Dallas Fort Worth Sarcoma Group, 4708 Alliance Blvd Ste 710., Plano, TX, 75093, USA.
Flavio A CalderonOrthopaedic Oncology, Dallas Fort Worth Sarcoma Group, 4708 Alliance Blvd Ste 710., Plano, TX, 75093, USA.
The University of Texas Health Science Center at Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDS AND

objectivesThe use of local antibiotic delivery vehicles is common in the management of biofilm-related infections as they provide high concentrations of local antibiotics while simultaneously avoiding complications from systemic toxicity. We present a 100% pure synthetic calcium sulfate hemi-hydrate mixed with 240 mg tobramycin and 500 mg vancomycin per 10 cc mixture for use in revision surgeries of periprosthetic joint infections (PJIs). The purified carrier demonstrates bioabsorbablity, promotion of bone growth, a physiologically favorable pH, and hydrophilicity. These unique properties may alleviate persistent postoperative wound drainage seen in patients with PJI. Our questions consist of two parts: (1) does the novel calcium sulfate carrier provide therapeutic concentrations of antibiotic locally that can kill biofilm related infections? (2) Are serum concentrations of antibiotic significant to cause concern for systemic toxicity?

methodsTo address these questions, we assayed the elution of antibiotic concentrations obtained from surgical drains and serum among 50 patients in the first 5 postoperative days.

resultsThe elution of vancomycin and tobramycin was greatest on day 1 compared with those concentrations obtained on days 2, 3, 4, and 5; serum concentrations were largely undetectable. Our findings demonstrate that this calcium sulfate preparation provides therapeutic delivery of vancomycin and tobramycin locally at log 2-3 above the minimum inhibitory concentration (MIC), while avoiding toxic serum concentrations.

conclusionsWhen used in one-stage revision arthroplasties, the bioabsorbable, purified carrier delivers high concentrations of antibiotic while avoiding systemic toxicity.

Indexed as

Drug CarriersAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBiofilmsCalcium SulfateDrainageDrug CombinationsDrug MonitoringFemaleHumansJoint ProsthesisMaleMiddle AgedAnti-Bacterial AgentsCalcium SulfateDrug CarriersDrug CombinationsStimulanTobramycinVancomycinAntibioticsBiofilmCalcium sulfate carrierInfected total joint prosthetics

Identifiers

PMID32328932
PMCPMC7359161
OpenAlexW3017617508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.